Fundamental Analysis of NANOVIBRONIX INC(NASDAQ:NAOV) stock

Fundamental Rating

NAOV gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 195 industry peers in the Health Care Equipment & Supplies industry. The financial health of NAOV is average, but there are quite some concerns on its profitability. While showing a medium growth rate, NAOV is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year NAOV has reported negative net income.

NAOV had a negative operating cash flow in the past year.

NAOV had negative earnings in each of the past 5 years.

In the past 5 years NAOV always reported negative operating cash flow.

1.2 Ratios

NAOV has a Return On Assets of -55.63%. This is in the lower half of the industry: NAOV underperforms 72.31% of its industry peers.

NAOV has a Return On Equity of -93.10%. This is in the lower half of the industry: NAOV underperforms 67.18% of its industry peers.

		Industry Rank	Sector Rank
ROA	-55.63%
ROE	-93.1%
ROIC	N/A

ROA(3y)-104.65%

ROA(5y)-130.08%

ROE(3y)-162.7%

ROE(5y)-219.63%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

NAOV's Gross Margin of 67.94% is fine compared to the rest of the industry. NAOV outperforms 75.38% of its industry peers.

In the last couple of years the Gross Margin of NAOV has grown nicely.

NAOV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	67.94%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y25.73%

GM growth 5Y6.13%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

NAOV does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, NAOV has more shares outstanding

The number of shares outstanding for NAOV has been increased compared to 5 years ago.

NAOV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

NAOV has an Altman-Z score of -14.03. This is a bad value and indicates that NAOV is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of -14.03, NAOV is not doing good in the industry: 83.08% of the companies in the same industry are doing better.

There is no outstanding debt for NAOV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-14.03

ROIC/WACCN/A

WACC10.1%

2.3 Liquidity

NAOV has a Current Ratio of 2.64. This indicates that NAOV is financially healthy and has no problem in meeting its short term obligations.

Looking at the Current ratio, with a value of 2.64, NAOV is in line with its industry, outperforming 42.05% of the companies in the same industry.

A Quick Ratio of 1.53 indicates that NAOV should not have too much problems paying its short term obligations.

NAOV has a worse Quick ratio (1.53) than 68.72% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.64
Quick Ratio	1.53

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 43.28% over the past year.

Looking at the last year, NAOV shows a very strong growth in Revenue. The Revenue has grown by 199.61%.

Measured over the past years, NAOV shows a very strong growth in Revenue. The Revenue has been growing by 48.14% on average per year.

EPS 1Y (TTM)43.28%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q69.57%

Revenue 1Y (TTM)199.61%

Revenue growth 3Y54.42%

Revenue growth 5Y48.14%

Revenue growth Q2Q1277%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

NAOV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

NAOV does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

NANOVIBRONIX INC

NASDAQ:NAOV (4/26/2024, 5:09:39 PM)

0.76

+0.01 (+1.33%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap2.11M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-55.63%
ROE	-93.1%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	67.94%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.34

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	2.64
Quick Ratio	1.53
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)43.28%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next YN/A

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)199.61%

Revenue growth 3Y54.42%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

NANOVIBRONIX INC (NAOV)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens